The majority of previous studies investigating AMFR and ROCK2 have focused on solid tumors, and only one demonstrated that the expression of AMFR was associated with progression in chronic lymphocytic leukemia (27). Here, AMFR is linked to B-cell chronic lymphocytic leukemia.